About TorreyPines Therapeutics
TorreyPines Therapeutics is a company based in San Diego (United States) founded in 2000 by Rudy Tanzi was acquired by Raptor Pharma in July 2009.. TorreyPines Therapeutics has raised $42.8 million across 3 funding rounds from investors including Novartis, Eisai and Gimv. TorreyPines Therapeutics offers products and services including DrugPatentWatch Service and Newsletter. TorreyPines Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter San Diego, United States
- Founders Rudy Tanzi
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thinkbiotech Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42.8 M (USD)
in 3 rounds
-
Latest Funding Round
$34.8 M (USD), Series C
Mar 17, 2005
-
Investors
Novartis
& 10 more
-
Employee Count
Employee Count
-
Acquired by
Raptor Pharma
(Jul 30, 2009)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TorreyPines Therapeutics
TorreyPines Therapeutics offers a comprehensive portfolio of products and services, including DrugPatentWatch Service and Newsletter. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for analyzing drug patent expirations and generic entry estimates.
Delivers updates on upcoming patent expirations and market trends.
Funding Insights of TorreyPines Therapeutics
TorreyPines Therapeutics has successfully raised a total of $42.8M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $34.8 million completed in March 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $34.8M
-
First Round
First Round
(27 Sep 2000)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2005 | Amount | Series C - TorreyPines Therapeutics | Valuation |
investors |
|
| Oct, 2002 | Amount | Series B - TorreyPines Therapeutics | Valuation |
investors |
|
| Sep, 2000 | Amount | Series A - TorreyPines Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TorreyPines Therapeutics
TorreyPines Therapeutics has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Novartis, Eisai and Gimv. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on healthcare companies
|
Founded Year | Domain | Location | |
|
Online slot gaming services are offered by ng24h platform.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TorreyPines Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TorreyPines Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Torreypines Therapeutics Comparisons
Competitors of TorreyPines Therapeutics
TorreyPines Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TorreyPines Therapeutics
When was TorreyPines Therapeutics founded?
TorreyPines Therapeutics was founded in 2000.
Where is TorreyPines Therapeutics located?
TorreyPines Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Is TorreyPines Therapeutics a funded company?
TorreyPines Therapeutics is a funded company, having raised a total of $42.8M across 3 funding rounds to date. The company's 1st funding round was a Series A of $8M, raised on Sep 27, 2000.
What does TorreyPines Therapeutics do?
TorreyPines Therapeutics (formerly Neurogenetics) was a clinical-stage company which was focused on developing small molecule drugs to treat CNS disorders like migraine, chronic pain, neuropathic pain, and Alzheimers disease. Its lead product NGX426 is an oral prodrug of tezampanel had finished Phase 1 trials for a migraine and neuropathic pain. Its other product NGX267 was a selective cholinergic muscarinic or M1 receptor agonist had finished phase II clinical trial product for the treatment of xerostomia. Additionally, it also developed Gamma-secretase modulator drug discovery program for the treatment of Alzheimers disease. In July 2009, it entered into a definitive merger agreement with Raptor Pharmaceuticals.
Who are the top competitors of TorreyPines Therapeutics?
TorreyPines Therapeutics's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.
What products or services does TorreyPines Therapeutics offer?
TorreyPines Therapeutics offers DrugPatentWatch Service and Newsletter.
Who are TorreyPines Therapeutics's investors?
TorreyPines Therapeutics has 11 investors. Key investors include Novartis, Eisai, Gimv, Raptor Pharma, and Johnson & Johnson Innovation – JJDC.